Oxford BioMedica plc (OXB) Habari na Bei kuhusu Hisa

Oxford Biomedica is a gene and cell therapy company specialising in the development of gene-based medicines. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. Wikipedia

Kuhusu Oxford BioMedica plc

Afisa Mkuu Mtendaji (CEO)Frank Mathias

Wafanyakazielfu 1.02

Lilianzishwa1995

Makao makuu-

Sekta-

Tovutioxb.com

Thamani zote katika GBP	Sep 2025	Des 2025	Mac 2026	Jun 2026
Mapato	47.76M	47.76M	39.92M	39.92M
Gharama ya bidhaa zilizouzwa	30.60M	30.60M	25.35M	25.35M
Gharama ya mapato	30.60M	30.60M	25.35M	25.35M
Gharama za utafiti na maendeleo	1.54M	1.54M	1.14M	1.14M
Jumla ya gharama za utafiti na maendeleo	-	-	-	-
Gharama za uuzaji, za jumla na za usimamizi	19.65M	19.65M	24.36M	24.36M
Gharama ya uendeshaji	20.93M	20.93M	25.29M	25.29M
Jumla ya gharama za uendeshaji	51.52M	51.52M	50.64M	50.64M
Mapato ya uendeshaji	-3.76M	-3.76M	-10.72M	-10.72M
Mapato mengine yasiyo ya uendeshaji	elfu -323.00	elfu -323.00	elfu -141.50	elfu -141.50
EBT ikijumuisha vipengee visivyo vya kawaida	-2.95M	-2.95M	-18.11M	-18.11M
EBT bila kujumuisha vipengee visivyo vya kawaida	-7.26M	-7.26M	-14.29M	-14.29M
Gharama ya kodi ya mapato	-1.07M	-1.07M	elfu 372.00	elfu 372.00
Kiwango cha kodi kinachotumika	36.20%	36.20%	-2.05%	-2.05%
Gharama nyingine za uendeshaji	elfu -259.50	elfu -259.50	elfu -212.50	elfu -212.50
Mapato halisi	-1.88M	-1.88M	-18.48M	-18.48M
Kiwango cha faida halisi	-3.94%	-3.94%	-46.29%	-46.29%
Mapato kwa kila hisa	-	-	-	-
Mapato ya riba na uwekezaji	elfu 649.50	elfu 649.50	elfu 917.00	elfu 917.00
Gharama ya riba	-3.55M	-3.55M	-3.94M	-3.94M
Jumla ya gharama halisi za riba	-2.90M	-2.90M	-3.02M	-3.02M
Gharama za kushuka kwa thamani na za kulipa deni	-	-	-	-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni	-2.06M	-2.06M	-7.43M	-7.43M
Faida au hasara kutokana na uuzaji wa vipengee	elfu 53.00	elfu 53.00	-	-

Fedha

Uliza chochote